Why Integra LifeSciences Stock Is Crashing Today
Shares of Integra LifeSciences (NASDAQ: IART) were crashing on Tuesday, with the stock falling 20.7% as of 3:39 p.m. ET. The steep decline came after the company revealed in a regulatory filing that it initiated a global recall of all SurgiMed, PriMatrix, Revize, and TissueMend surgical tissue products made in its Boston, Massachusetts facility that were distributed between March 1, 2018, and May 22, 2023. Manufacturing at this facility will also be temporarily suspended.
Integra stated that the recall was voluntary. However, it was done "after consultation with the U.S. Food and Drug Administration."
The company said that an internal investigation found that products could have been distributed with higher levels of endotoxins than are allowed. These endotoxins can cause an immune response.
Source Fool.com
Integra LifeSciences Holdings Corp Aktie
Ausgeglichenes Feld: 3 Buy- stehen 4 Sell-Einschätzungen bei Integra LifeSciences Holdings Corp gegenüber.
Obwohl das Kursziel von 24 € über dem aktuellen Kurs von 23.0 € für Integra LifeSciences Holdings Corp liegt, zeigt sich ein positives Potenzial von 4.35%.
